Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi(TM) (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo

Bactericidal antibiotic cream indicated for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older Demonstrated activity against most isolates both in vitro and in clini... Biopharmaceuticals, Dermatology, FDA Medimetriks Pharmaceuticals, Xepi, ozenoxacin, Impetigo
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news